Detalles de la búsqueda
1.
Extracellular Vesicles Derived from Type 2 Diabetic Mesenchymal Stem Cells Induce Endothelial Mesenchymal Transition under High Glucose Conditions Through the TGFß/Smad3 Signaling Pathway.
Stem Cells Dev
; 33(11-12): 262-275, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38717965
2.
Extracellular vesicles derived from SARS-CoV-2 M-protein-induced triple negative breast cancer cells promoted the ability of tissue stem cells supporting cancer progression.
Front Oncol
; 14: 1346312, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38515582
3.
Impairment of HIF-2α Expression Induced the Compensatory Overexpression of the HIF-1α/SDF-1 Axis to Promote Wound Healing.
Stem Cells Dev
; 32(19-20): 592-605, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37392019
4.
SARS-CoV-2 M Protein Facilitates Malignant Transformation of Breast Cancer Cells.
Front Oncol
; 12: 923467, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35747796
5.
Type 2 Diabetes Mellitus Promotes the Differentiation of Adipose Tissue-Derived Mesenchymal Stem Cells into Cancer-Associated Fibroblasts, Induced by Breast Cancer Cells.
Stem Cells Dev
; 31(21-22): 659-671, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35734905
6.
Transformed extracellular vesicles with high angiogenic ability as therapeutics of distal ischemic tissues.
Front Cell Dev Biol
; 10: 869850, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36120585
7.
Extracellular vesicles derived from Wharton's Jelly mesenchymal stem cells inhibit the tumor environment via the miR-125b/HIF1α signaling pathway.
Sci Rep
; 12(1): 13550, 2022 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35941273
Resultados
1 -
7
de 7
1
Próxima >
>>